Edition:
United Kingdom

Poxel SA (POXEL.PA)

POXEL.PA on Paris Stock Exchange

5.20EUR
4:35pm GMT
Change (% chg)

€-0.09 (-1.70%)
Prev Close
€5.29
Open
€5.26
Day's High
€5.27
Day's Low
€5.17
Volume
51,952
Avg. Vol
57,994
52-wk High
€8.18
52-wk Low
€4.92

Chart for

About

Poxel SAS is a France-based company principally engaged in the biopharmaceutical sector. The Company develops drugs with a focus on Type 2 diabetes. The Company aims at developing drugs from preclinical to phase 2 clinical proof of concept. Its lead product, Imeglimin, is in clinical phase 2 study for Type 2 diabetes indication.... (more)

Overall

Beta: --
Market Cap(Mil.): €144.47
Shares Outstanding(Mil.): 22.93
Dividend: --
Yield (%): --

Financials

  POXEL.PA Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -0.96 -- --
ROI: -74.43 8.99 14.48
ROE: -76.50 10.14 15.99

Earnings vs. Estimates